Tanaka Capital Management »

Nuvation Bio shares owned by Tanaka Capital Management

Quarter-by-quarter ownership of Nuvation Bio (NUVB) shares owned by Tanaka Capital Management from 13F filings

Historical chart of Tanaka Capital Management investment in Nuvation Bio

Tip: Access up to 7 years of quarterly data

All positions including Nuvation Bio held by Tanaka Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvation Bio by Tanaka Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.5M 685k 3.70

More positions owned by Tanaka Capital Management

Corcept Therapeutics Incorporated (CORT)
United States Antimony (UAMY)
NVIDIA Corporation (NVDA)
Nexgen Energy (NXE)
Apple (AAPL)
Nuvation Bio (NUVB)
iShares S&P SmallCap 600 Index (IJR)
Symbotic (SYM)
AFLAC Incorporated (AFL)
Catalyst Pharmaceutical Partners (CPRX)
Carlyle Group
Onto Innovation (ONTO)
Electrovaya (ELVA)
Stifel Financial (SF)
Applied Materials (AMAT)

View all positions for Tanaka Capital Management

Top funds holding Nuvation Bio

FMR
Decheng Capital
BlackRock
Vanguard Group
Laurion Capital Management
Omega Fund Management
State Street Corporation
Geode Capital Management
Millennium Management
Nuveen
Tang Capital Management
Abrams Capital Management
Dimensional Fund Advisors
Redmile Group
Aisling Capital Management

View all funds holding Nuvation Bio